Scleritis in Systemic Sclerosis Treated With Infliximab Biosimilar.

An 84-year-old woman diagnosed in 2002 with limited cutaneous systemic sclerosis (SSc) that is characterized by sclerodactyly, telangiectasia, Raynaud phenomenon, gastroesophageal reflux, and antinuclear antibodies, but negative for ScL70 and anticentromere antibody, presented with left eye redness and pain. Her gastroesophageal reflux was treated with pantoprazole, and her comorbid inflammatory osteoarthritis was treated with hydroxychloroquine.